Blood test could spot hidden cancers in High-Risk patients

NCT ID NCT04261972

Ongoing Diagnosis Sponsor: University Health Network, Toronto Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is developing a blood test to find early-stage tumors in people with hereditary cancer syndromes (high genetic risk for cancer). Researchers will collect blood samples and medical data from about 1,400 participants across Canada. They will also interview patients and doctors to see if this test is useful and practical for routine cancer screening.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEREDITARY CANCER SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Colorectal Neoplasms, Hereditary Nonpolyposis hereditary breast ovarian cancer syndrome hereditary neoplastic syndrome neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEREDITARY CANCER SYNDROME

Contacts and locations

Show contact details

Locations

BC Cancer Agency

Vancouver, British Columbia, V5Z 4E6, Canada
Eastern Health

St. John's, Newfoundland and Labrador, A1B 3V6, Canada
IWK Health Centre

Halifax, Nova Scotia, B3K 6R8, Canada
Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada
Sinai Health System

Toronto, Ontario, M5G 1X5, Canada
University Health Network

Toronto, Ontario, M5G 2M9, Canada
Women's College Hospital

Toronto, Ontario, M5S 1B2, Canada